Haleon

Haleon Sees Revenue Up 13.4% In First Half

British consumer healthcare company Haleon, which GSK recently officially spun off, has reported revenue growth of 13.4% (up 11.6% in t), to £5.2 bil...

Haleon Posts Revenue Growth In First Half

British consumer healthcare company Haleon, which GSK recently officially spun off, has posted a trading update for the six months ended 30 June 2022.

GSK Announces Board And Committee Changes

Global biopharma company GSK has announced a number of changes to its board and committees, which are set to take effect immediately following the demerger...

GSK Spins Off Haleon In Biggest European Listing For A Decade

GSK has officially spun off its consumer health business, Haleon, in the biggest listing in Europe for more than a decade.

GSK Spins Off Consumer Health Business Worth Up To $57bn

British drugmaker GSK will spin off its consumer health business Haleon worth up to an estimated £48 billion ($57 billion) on Monday in the biggest l...

Pfizer Set To Exit GSK's Consumer Health Arm After Spin-Off

Pfizer plans to exit its 32% stake in Haleon, its consumer health joint venture with British drugmaker GSK, after the business is spun off as an independen...

GSK Says Consumer Arm Spin-Off 'On Track', Stands By Forecasts

Britain's GSK beat analyst expectations for its first-quarter results on Wednesday and stood by its forecasts for 2022, ahead of the planned listing of its...

GSK To Float Consumer Arm In July Despite Volatile Markets

GSK said on Monday it would float its consumer healthcare business on the stock market in July, confirming listing plans amid market jitters and after reje...

Subscribe Today

Page 3

Get the app today!